Your search returned 5959 results.

Results
	5741.	Sunitinib, sorafenib and mTOR inhibitors in renal cancer. [electronic resource] by Radulovic, Sinisa Bjelogrlic, Snezana K Producer: 20071121 In: Journal of B.U.ON. : official journal of the Balkan Union of Oncology vol. 12 Suppl 1 Availability: No items available. Save to lists Add to cart (remove)
	5742.	Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. [electronic resource] by Huang, Shengbing Sinicrope, Frank A Producer: 20100618 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5743.	Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. [electronic resource] by Lee, Hwa Jin Wall, Brian A Wangari-Talbot, Janet Shin, Seung-Shick Rosenberg, Stephen Chan, Joseph L-K Namkoong, Jin Goydos, James S Chen, Suzie Producer: 20120325 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5744.	Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice. [electronic resource] by Eicher, Carmen Dewerth, Alexander Kirchner, Bettina Warmann, Steven W Fuchs, Joerg Armeanu-Ebinger, Sorin Producer: 20120719 In: Liver international : official journal of the International Association for the Study of the Liver vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5745.	Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. [electronic resource] by Peer, Cody J Sissung, Tristan M Kim, Aerang Jain, Lokesh Woo, Sukyung Gardner, Erin R Kirkland, C Tyler Troutman, Sarah M English, Bevin C Richardson, Emily D Federspiel, Joel Venzon, David Dahut, William Kohn, Elise Kummar, Shivaani Yarchoan, Robert Giaccone, Giuseppe Widemann, Brigitte Figg, William D Producer: 20120823 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5746.	Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. [electronic resource] by Duncan, James S Whittle, Martin C Nakamura, Kazuhiro Abell, Amy N Midland, Alicia A Zawistowski, Jon S Johnson, Nancy L Granger, Deborah A Jordan, Nicole Vincent Darr, David B Usary, Jerry Kuan, Pei-Fen Smalley, David M Major, Ben He, Xiaping Hoadley, Katherine A Zhou, Bing Sharpless, Norman E Perou, Charles M Kim, William Y Gomez, Shawn M Chen, Xin Jin, Jian Frye, Stephen V Earp, H Shelton Graves, Lee M Johnson, Gary L Producer: 20120608 In: Cell vol. 149 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5747.	B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger. [electronic resource] by Karki, Pratap Li, Xiuju Schrama, David Fliegel, Larry Producer: 20110628 In: The Journal of biological chemistry vol. 286 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5748.	A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study. [electronic resource] by Crump, Michael Hedley, David Kamel-Reid, Suzanne Leber, Brian Wells, Richard Brandwein, Joseph Buckstein, Rena Kassis, Janine Minden, Mark Matthews, John Robinson, Sue Turner, Robert McIntosh, Lynn Eisenhauer, Elizabeth Seymour, Lesley Producer: 20100423 In: Leukemia & lymphoma vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5749.	FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy. [electronic resource] by Katz, Sharyn I Zhou, Lanlan Ferrara, Thomas A Wang, Wenge Mayes, Patrick A Smith, Charles D El-Deiry, Wafik S Producer: 20110909 In: International journal of oncology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5750.	Third-line sorafenib after sequential therapy with sunitinib and mTOR inhibitors in metastatic renal cell carcinoma. [electronic resource] by Di Lorenzo, Giuseppe Buonerba, Carlo Federico, Piera Rescigno, Pasquale Milella, Michele Ortega, Cinzia Aieta, Michele D'Aniello, Carmine Longo, Nicola Felici, Alessandra Ruggeri, Enzo Maria Palmieri, Giovannella Imbimbo, Ciro Aglietta, Massimo De Placido, Sabino Mirone, Vincenzo Producer: 20110707 In: European urology vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5751.	Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells. [electronic resource] by Ricciardi, Simona Mey, Valentina Nannizzi, Sara Pasqualetti, Giuseppe Crea, Francesco Del Tacca, Mario Danesi, Romano Producer: 20101213 In: Chemotherapy vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5752.	Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. [electronic resource] by D'Argenio, Giuseppe Valenti, Marta Scaglione, Giuseppe Cosenza, Vittorio Sorrentini, Italo Di Marzo, Vincenzo Producer: 20060421 In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5753.	COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. [electronic resource] by Yoshida, Satoko Amano, Hideki Hayashi, Izumi Kitasato, Hidero Kamata, Mariko Inukai, Madoka Yoshimura, Hirokuni Majima, Masataka Producer: 20031106 In: Laboratory investigation; a journal of technical methods and pathology vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5754.	The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages. [electronic resource] by Edwards, Justin P Emens, Leisha A Producer: 20110215 In: International immunopharmacology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5755.	von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. [electronic resource] by Choueiri, Toni K Vaziri, Susan A J Jaeger, Erich Elson, Paul Wood, Laura Bhalla, Ish Prasad Small, Eric J Weinberg, Vivian Sein, Nancy Simko, Jeff Golshayan, Ali-Reza Sercia, Linda Zhou, Ming Waldman, Frederic M Rini, Brian I Bukowski, Ronald M Ganapathi, Ram Producer: 20080918 In: The Journal of urology vol. 180 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5756.	Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf. [electronic resource] by Matsuzawa, Yasuo Kiuchi, Yoshiaki Toyomura, Kaori Matsumoto, Ikiru Nakamura, Hiroyuki Fujino, Hiromichi Murayama, Toshihiko Kawashima, Tatsuo Producer: 20100128 In: Journal of pharmacological sciences vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5757.	The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro. [electronic resource] by von Bubnoff, N Gorantla, S P Engh, R A Oliveira, T M Thöne, S Aberg, E Peschel, C Duyster, J Producer: 20110413 In: Oncogene vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5758.	Sorafenib: a promising new targeted therapy for renal cell carcinoma. [electronic resource] by Wood, Laura S Manchen, Beth Producer: 20071220 In: Clinical journal of oncology nursing vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5759.	Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. [electronic resource] by Rahmani, Mohamed Aust, Mandy Mayo Attkisson, Elisa Williams, David C Ferreira-Gonzalez, Andrea Grant, Steven Producer: 20120913 In: Blood vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5760.	Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma. [electronic resource] by Piguet, Anne-Christine Saar, Bettina Hlushchuk, Ruslan St-Pierre, Marie V McSheehy, Paul M J Radojevic, Vesna Afthinos, Maresa Terracciano, Luigi Djonov, Valentin Dufour, Jean-François Producer: 20111109 In: Molecular cancer therapeutics vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 5959 results.